# Remifentanil and Desflurane Inhalational Anesthesia in Bariatric Surgeries

> **NCT03219788** · PHASE2 · UNKNOWN · sponsor: **Assiut University** · enrollment: 120 (estimated)

## Conditions studied

- Anesthesia Emergence

## Interventions

- **DRUG:** Normal Saline
- **DRUG:** Remifentanil 0.1 ug/kg
- **DRUG:** Remifentanil 0.2 ug/kg

## Key facts

- **NCT ID:** NCT03219788
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-20
- **Primary completion:** 2017-11-01
- **Final completion:** 2017-11-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2017-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03219788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03219788, "Remifentanil and Desflurane Inhalational Anesthesia in Bariatric Surgeries". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03219788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*